Indus Gene Expressions Limited

Indus Gene Expressions Limited - life sciences in Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24231AP2007PLC113311 Incorporated 09 February 2007 ROC Vijayawada HQ Andhra Pradesh, India
Active Public Limited Company life sciences MSME · Small
Data last updated
Revenue · FY 2023
₹16.82 Cr
▲ 570% YoY
Net profit · FY 2023
₹10.28 Lakh
Net margin 0.6%
EBITDA · FY 2023
₹11.71 Cr
EBITDA margin 69.6%
Authorised capital
₹100 Cr
Registered with MCA
Paid-up capital
₹92.83 Cr
Issued & subscribed
Open charges
₹32.63 Cr
Satisfied ₹30.4 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
29
Provident fund records

About Indus Gene Expressions Limited

Data last updated:

Indus Gene Expressions Limited is a public limited company based in Andhra Pradesh, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 09 February 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24231AP2007PLC113311. Its GSTIN is 37AABCI9124R1ZY (Andhra Pradesh).

The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹92.83 Cr. It was formerly known as Indus Gene Expressions Private Limited and Sri Balaji Biopharmaceuticals India Private Limited. It is led by directors including Channa Reddy C and Meka Sudhakara Reddy.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 6 – 312 Kodur Village Kanisettipalli Post, Andhra Pradesh, India – 515341.

As per the financials filed for FY 2023, the company reported a revenue of ₹16.82 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10.28 Lakh (net margin 0.6%) and EBITDA of ₹11.71 Cr (EBITDA margin 69.6%). Revenue has grown at a compounded annual rate (CAGR) of 639% over five years.

The company has about 29 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹32.63 Cr and satisfied charges of ₹30.4 Cr on record. Court records list 10 cases involving the company, including 9 filed by the company and 1 filed against it; 3 cases are pending. The company has 24 deals on record (18 secondary share transfers, 6 funding rounds), with disclosed funding of ₹63.95 Cr; the latest was in May 2022. The company has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 17 overdue payments to 9 micro and small suppliers.

Indus Gene Expressions Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-01-0000020). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indusgenetech.com.

Company details

CIN U24231AP2007PLC113311
Registration Number 113311
Incorporation Date 09 February 2007
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-01-0000020

Name history

Indus Gene Expressions has undergone 2 name changes throughout its history. The company was previously known as Indus Gene Expressions Private Limited, and Sri Balaji Biopharmaceuticals India Private Limited. The current legal name is Indus Gene Expressions Limited.

Company NameStatus
Indus Gene Expressions LimitedCurrent
Indus Gene Expressions Private LimitedPrevious
Sri Balaji Biopharmaceuticals India Private LimitedPrevious

CIN history

Indus Gene Expressions has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231AP2007PLC113311, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231AP2007PLC113311Current
U24231KA2007PLC041743Previous
U24231KA2007PTC041743Previous
Key People
Usharani Reddy C Cfo Channa Reddy C Director Meka Sudhakara Reddy Additional Director

Recognitions & Rankings of Indus Gene Expressions

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-AP-01-0000020

Contact details

Indus Gene Expressions Limited's registered office is in Andhra Pradesh. Its website is indusgenetech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    indusgenetech.com
  • Registered Address
    6 – 312 Kodur Village Kanisettipalli Post, Andhra Pradesh, India – 515341
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Indus Gene Expressions Limited, buy the company report.

Comprehensive company report
Indus Gene Expressions Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Indus Gene Expressions Limited

FY 2023 filings available

Indus Gene Expressions Limited reported revenue of ₹16.82 Cr (up 570% YoY) for FY 2023.

Revenue · FY 2023
₹16.82 Cr ▲ 570%
Net profit · FY 2023
₹10.28 Lakh margin 0.6%
EBITDA · FY 2023
₹11.71 Cr margin 69.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 570%
5 years · compounded
▲ 639%
EBITDA CAGR growth
3 years · compounded
▲ 519%
5 years · compounded
▲ 356%

Revenue has grown at a compounded annual rate (CAGR) of 639% over five years, including 570% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹16.82 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.71 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹10.28 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin69.6%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Indus Gene Expressions Limited, buy the company report.

Board of directors and KMP of Indus Gene Expressions Limited

Indus Gene Expressions Limited currently reports 5 directors and 1 key managerial person. 16 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Usharani Reddy C
Also directs: Dr.Reddy Solar Energy and Systems Private Limited
Cfo03 Apr 20197 Years 7 MonthsCurrent
Channa Reddy C
Also directs: Pennzymes International Private Limited, Dr.Reddy Solar Energy and Systems Private Limited
Director06 Nov 200818 Years 0 MonthsCurrent
Meka Sudhakara ReddyAdditional Director06 May 20224 Years 6 MonthsCurrent
Avula Sreenivasa ReddyAdditional Director28 Oct 20197 Years 0 MonthsCurrent
Muktha Puram KrishnaAdditional Director28 Sep 20242 Years 1 MonthsCurrent
Abhinaya Chinthamani ReddyAdditional Director15 Jan 20251 Years 9 MonthsCurrent
View all directors and KMP

Shareholding

The shareholding of Indus Gene Expressions Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Indus Gene Expressions Limited, buy the company report.

Charges & borrowings

Open charges
₹32.63 Cr
Satisfied charges
₹30.4 Cr
Breakdown by lending institutions
Syndicate Bank₹29.00 Cr
Canara Bank₹3.63 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Sep 2020100369900Canara Bank₹3.63 CrOpen
21 Dec 2019100313774Syndicate Bank₹29 CrOpen
13 Oct 201410528020Andhra Bank₹30.4 CrSatisfied

To see the full charge records of Indus Gene Expressions Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Indus Gene Expressions Limited has 24 deals on record (18 secondary share transfers, 6 funding rounds), with disclosed funding of ₹63.95 Cr; the latest was in May 2022.

Total deals
24
Secondary share transfers
18
Funding rounds
6
Disclosed funding
₹63.95 Cr

Deals on record (5 of 24)

WhenDealAmountParties
May 2022Funding round₹2.06 CrInvestors: an individual
Jul 2021Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jul 2021Funding round₹12.8 CrInvestors: an individual
Mar 2021Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Mar 2021Secondary share transferUndisclosedBuyer: Tri Solar Private Limited
Seller: an individual

To see the full deal history of Indus Gene Expressions Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Indus Gene Expressions Limited was last rated by Care on 14 Jul 2022.

Rating agencyRated onRating
Care14 Jul 2022

To see the full credit ratings and regulatory alerts of Indus Gene Expressions Limited, buy the company report.

MSME payment delays

Indus Gene Expressions Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 17 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 9)

SupplierAmount dueDue sinceReported on
Kala G Granite
Elite Associates
Sunlight Gas & Equipments Private Limited
Shivani Interior Solutions Private Limited
C4g Automation Private Limited

To see the full MSME payment records of Indus Gene Expressions Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Indus Gene Expressions has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AABCI9124R1ZYAndhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Indus Gene Expressions Limited, buy the company report.

Recent activity

Indus Gene Expressions Limited has 19 board changes on record since 2008: 6 appointments and 13 cessations. The latest: Tanvi Sahu ceased to be Company Secretary on 31 Jan 2025.

Ceased
Tanvi Sahu ceased to be Company Secretary.
Appointed
Abhinaya Chinthamani Reddy was appointed as Additional Director.
Ceased
Vemula Nilima ceased to be Additional Director.
Appointed
Muktha Puram Krishna was appointed as Additional Director.
Ceased
Muktha Puram Krishna ceased to be Additional Director.
Ceased
Rupana Reddy Nallari ceased to be Director.
AGM
Indus Gene Expressions Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Indus Gene Expressions Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada.
Appointed
Meka Sudhakara Reddy was appointed as Additional Director.
Charges
A charge with Canara Bank amounted to Rs. 3.63 Cr with Charge ID 100369900 was registered on 04 Sep 2020.
Ceased
Prasada Reddy Kambham ceased to be Director.
Charges
A charge with Syndicate Bank amounted to Rs. 29.00 Cr with Charge ID 100313774 was registered on 21 Dec 2019.

14 earlier events are in the company report.

Frequently asked questions

Indus Gene Expressions is an active public limited company based in Andhra Pradesh, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 09 February 2007 (19+ years old) and is registered under CIN U24231AP2007PLC113311.

Indus Gene Expressions has 6 current directors and KMP:

The latest financial statements of Indus Gene Expressions on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.

The GSTIN of Indus Gene Expressions is 37AABCI9124R1ZY, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Indus Gene Expressions is U24231AP2007PLC113311. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Indus Gene Expressions has 10 court cases on record: 9 filed by the company and 1 filed against it. 3 are pending. Most are in the high courts.

Indus Gene Expressions was incorporated on 09 February 2007, making it 19+ years old. It is registered with the Registrar of Companies, Vijayawada.

Indus Gene Expressions has 24 deals on record (18 secondary share transfers, 6 funding rounds), with disclosed funding of ₹63.95 Cr; the latest was in May 2022.

Tanvi Sahu ceased to be Company Secretary on 31 Jan 2025. Abhinaya Chinthamani Reddy was appointed as Additional Director on 15 Jan 2025. Vemula Nilima ceased to be Additional Director on 17 Dec 2024. Indus Gene Expressions has 19 board changes on record in total.

Yes, Indus Gene Expressions is registered as a small enterprise under Udyam registration (number: UDYAM-AP-01-0000020).

Indus Gene Expressions has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 17 overdue payments to 9 micro and small suppliers. The latest return was filed on 15 Dec 2019.